Registration - Amendment

SANOFI US SERVICES INC. for SANOFI US SERVICES INC

Period Year-End 2007 Filed Dec 11, 2007

Official filing
Firm
SANOFI US SERVICES INC.
Client
SANOFI US SERVICES INC
Income
—
Expenses
—

What was lobbied

9 issue areas, each in the filer's own words, with who lobbied on it and where.

Manufacturing MAN

FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; follow-on biogics (biosimilars); manufacturer pricing or rebate obligations and patient access under government programs such as Medicaid and Medicare; animals in research; military & veterans health care programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.

LobbyistCovered position, as disclosed
TIMOTHY CLARK New N/A
MARK COIN New N/A
EDDIE D EVANS New N/A
EDWARD GREISSING New N/A
RICHARD M HODGE New N/A
JONATHAN SPEAR New N/A
SAIRA SULTAN New N/A
ANN TAYLOR New N/A

Health Issues HCR

FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; follow-on biogics (biosimilars); manufacturer pricing or rebate obligations and patient access under government programs such as Medicaid and Medicare; animals in research; military & veterans health care programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.

LobbyistCovered position, as disclosed
TIMOTHY CLARK New N/A
MARK COIN New N/A
EDDIE D EVANS New N/A
EDWARD GREISSING New N/A
RICHARD M HODGE New N/A
JONATHAN SPEAR New N/A
SAIRA SULTAN New N/A
ANN TAYLOR New N/A

Copyright/Patent/Trademark CPT

FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; follow-on biogics (biosimilars); manufacturer pricing or rebate obligations and patient access under government programs such as Medicaid and Medicare; animals in research; military & veterans health care programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.

LobbyistCovered position, as disclosed
TIMOTHY CLARK New N/A
MARK COIN New N/A
EDDIE D EVANS New N/A
EDWARD GREISSING New N/A
RICHARD M HODGE New N/A
JONATHAN SPEAR New N/A
SAIRA SULTAN New N/A
ANN TAYLOR New N/A

Medicare/Medicaid MMM

FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; follow-on biogics (biosimilars); manufacturer pricing or rebate obligations and patient access under government programs such as Medicaid and Medicare; animals in research; military & veterans health care programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.

LobbyistCovered position, as disclosed
TIMOTHY CLARK New N/A
MARK COIN New N/A
EDDIE D EVANS New N/A
EDWARD GREISSING New N/A
RICHARD M HODGE New N/A
JONATHAN SPEAR New N/A
SAIRA SULTAN New N/A
ANN TAYLOR New N/A

Budget/Appropriations BUD

FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; follow-on biogics (biosimilars); manufacturer pricing or rebate obligations and patient access under government programs such as Medicaid and Medicare; animals in research; military & veterans health care programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.

LobbyistCovered position, as disclosed
TIMOTHY CLARK New N/A
MARK COIN New N/A
EDDIE D EVANS New N/A
EDWARD GREISSING New N/A
RICHARD M HODGE New N/A
JONATHAN SPEAR New N/A
SAIRA SULTAN New N/A
ANN TAYLOR New N/A

Chemicals/Chemical Industry CHM

FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; follow-on biogics (biosimilars); manufacturer pricing or rebate obligations and patient access under government programs such as Medicaid and Medicare; animals in research; military & veterans health care programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.

LobbyistCovered position, as disclosed
TIMOTHY CLARK New N/A
MARK COIN New N/A
EDDIE D EVANS New N/A
EDWARD GREISSING New N/A
RICHARD M HODGE New N/A
JONATHAN SPEAR New N/A
SAIRA SULTAN New N/A
ANN TAYLOR New N/A

Animals ANI

FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; follow-on biogics (biosimilars); manufacturer pricing or rebate obligations and patient access under government programs such as Medicaid and Medicare; animals in research; military & veterans health care programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.

LobbyistCovered position, as disclosed
TIMOTHY CLARK New N/A
MARK COIN New N/A
EDDIE D EVANS New N/A
EDWARD GREISSING New N/A
RICHARD M HODGE New N/A
JONATHAN SPEAR New N/A
SAIRA SULTAN New N/A
ANN TAYLOR New N/A

Medical/Disease Research/Clinical Labs MED

FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; follow-on biogics (biosimilars); manufacturer pricing or rebate obligations and patient access under government programs such as Medicaid and Medicare; animals in research; military & veterans health care programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.

LobbyistCovered position, as disclosed
TIMOTHY CLARK New N/A
MARK COIN New N/A
EDDIE D EVANS New N/A
EDWARD GREISSING New N/A
RICHARD M HODGE New N/A
JONATHAN SPEAR New N/A
SAIRA SULTAN New N/A
ANN TAYLOR New N/A

Advertising ADV

FDA-related legislation; DTC advertising; authorized generics/patent and Hatch-Waxman reform; follow-on biogics (biosimilars); manufacturer pricing or rebate obligations and patient access under government programs such as Medicaid and Medicare; animals in research; military & veterans health care programs involving prescription medications; pharmaceutical drug importation; CMS coverage & reimbursement; corporate tax legislation; legal reform issues.

LobbyistCovered position, as disclosed
TIMOTHY CLARK New N/A
MARK COIN New N/A
EDDIE D EVANS New N/A
EDWARD GREISSING New N/A
RICHARD M HODGE New N/A
JONATHAN SPEAR New N/A
SAIRA SULTAN New N/A
ANN TAYLOR New N/A

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
SANOFI-AVENTIS SA France France 100.0% —

Affiliated organisations

OrganisationLocation
SANOFI-AVENTIS U.S. LLC US

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.